1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Beryl Drugs
Beryl Drugs Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Beryl Drugs Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
New 52W Low in past week
-44.4
Dividend yield 1yr %
0
Beryl Drugs Key Financials
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Beryl Drugs Quarterly Revenue
| Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 |
|---|---|---|---|---|
4.73 Cr | 3.63 Cr | 3.24 Cr | 4.88 Cr | 2.51 Cr |
Beryl Drugs Yearly Revenue
| Mar 2018 | Mar 2017 |
|---|---|
15.99 Cr | 11.53 Cr |
Beryl Drugs Quarterly Net Profit/Loss
| Mar 2018 | Dec 2017 | Sep 2017 | Jun 2017 | Mar 2017 |
|---|---|---|---|---|
0.88 Cr | 0.1 Cr | 0.09 Cr | 0.03 Cr | -0.02 Cr |
Beryl Drugs Yearly Net Profit/Loss
| Mar 2018 | Mar 2017 |
|---|---|
0.99 Cr | -0.41 Cr |
Beryl Drugs Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
22.50
10Day EMA
23.10
12Day EMA
23.40
20Day EMA
24.30
26Day EMA
25.10
50Day EMA
27.70
100Day EMA
30.60
200Day EMA
31.80
5Day SMA
22.80
10Day SMA
23.20
20Day SMA
23.90
30Day SMA
25.30
50Day SMA
28.90
100Day SMA
32.40
150Day SMA
34.00
200Day SMA
33.50
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 6577 Rs | 6821 Rs |
Week Rs | 7672 Rs | 8643 Rs |
Month Rs | 8941 Rs | 10074 Rs |
Resistance & Support
21.37
Pivot
Resistance
First Resistance
21.90
Second Resistance
22.74
Third Resistance
23.27
Support
First Support
20.53
Second support
20.00
Third Support
19.16
Relative Strength Index
34.37
Money Flow Index
19.12
MACD
-1.74
MACD Signal
-1.82
Average True Range
2.49
Average Directional Index
19.97
Rate of Change (21)
-21.01
Rate of Change (125)
-44.40
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Kabra Drugs Ltd. | - | - | - | |
Beryl Drugs Ltd. | - | - | - | |
Decipher Labs Ltd. | - | - | - | |
Venmax Drugs & Pharmaceuticals Ltd. | - | - | - | |
Desh Rakshak Aushdhalaya Ltd. | - | - | - | |
Unjha Formulations Ltd. | - | - | - | |
Cian Healthcare Ltd. | - | - | - |
Beryl Drugs Company background
Founded in: 1993
Managing director: Sanjay Sethi
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company were listed on M.P. Stock Exchange, Bombay Stock Exchange and Ahmedabad Stock Exchange.The Company thereafter has been engaged in the manufacture, sale, and export of branded, generic pharmaceutical formulations in India and internationally. It offers I.V.fluids, and a range of small and large volume injectables. It provides a range of eye/ear drops, veterinary products, and injections. It sells products through sales and distribution network. In addition, it offers research and development, as well as contract manufacturing services. Beryl Drugs Ltd. is based in Indore, India.Beryl emerged into a global network of pharmaceutical manufacturing, research and development, contract manufacturing services and veterinary products. It owns brands like BERICEF injection, FNeuron, Amplicillin INJ, PMol, Biprox, BFlox and many more.The manufacturing facilities of the Company are in compliance with WHO GMP specifications. The Company is in tune with the current manufacturing trends in healthcare industry. The Company is an ISO 9001:2000 certified for quality management, which acknowledges quality as the first and the foremost important aspect into the business of healthcare products.
Beryl Drugs FAQs
How to buy Beryl Drugs shares?
You can easily buy Beryl Drugs shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Beryl Drugs stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
